GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.00
Bid: 26.00
Ask: 28.00
Change: 1.10 (4.25%)
Spread: 2.00 (7.692%)
Open: 25.90
High: 27.00
Low: 25.90
Prev. Close: 25.90
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fuel Cell Catalyst Patent Granted in Japan

1 May 2013 07:00

RNS Number : 6723D
Ilika plc
01 May 2013
 



 

Ilika plc

("Ilika" or the "Company")

 

Fuel Cell Catalyst Patent Granted in Japan

 

Ilika (AIM: IKA), the advanced cleantech materials company, announces that further to the granting of its patent application covering its lower cost metal alloys and their use as electro-catalysts in PEM fuel cells in the USA, it has also received notification that this patent has now been granted in Japan.

 

In a PEM fuel cell, a controlled reaction occurs between hydrogen and oxygen. This reaction requires electro-catalysts, which are currently based on the precious metal, platinum. Ilika has developed a novel platinum-free catalyst, which on a cost/performance basis, has been shown to be 70% cheaper than the current industry standard. Ilika's electro-catalysts, which were originally invented using its high throughput materials development platform at its facility in Southampton, UK, have been subsequently manufactured to Ilika's specification by a partner using an industrially-scalable process.

 

As communicated in Ilika's Trading update released in April 2013, Ilika has submitted positive cell performance data and material samples for evaluation by select automotive manufacturers based primarily in the US and Japan. Therefore, the grant of this patent in both the USA and Japan confirms that the Company has secured the intellectual property in two of the major markets in which Ilika intends to commercialise its proprietary technology.

 

Furthermore, Ilika's development partner in Taiwan has now successfully manufactured the catalyst material, which is a critical component of the PEM fuel cell, to Ilika's specification at the kilogram scale. This development progress ensures that the industrial production process can be readily transferred to any volume-manufacturing partner.

 

Ilika's patents underpin the product development work, which is being supported by the Carbon Trust through the £150,000 equity investment Ilika announced in September 2012. The Carbon Trust invested in Ilika through its Polymer Fuel Cells Challenge programme to support the commercialization of Ilika's high performing electro-catalysts for use in fuel cell vehicles. As part of the Carbon Trust's technical and commercial evaluation of the technology, Ilika submitted performance data for assessment by independent experts demonstrating the performance and stability of the catalyst. The performance data was generated in industry standard tests of membrane electrode assemblies (MEA's) carried out at an independent fuel cell testing facility. The investment from the Carbon Trust is currently supporting Ilika in having a larger quantity of the electro-catalyst made for testing by the major automotive OEMs that have expressed their interest in the technology.

 

Graeme Purdy, Chief Executive of Ilika, added:"The grant of this patent in Japan builds on the Company's IP position in the USA and is an important stepping-stone in reinforcing the commercial value of Ilika's technology in this area. From a revenue perspective, Japan continues to be the most important jurisdiction for the Company and our team there is now broadening its customer interactions for commercialising this technology".

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or ilika@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or ilika@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURANROBASOAR
Date   Source Headline
26th Aug 20207:00 amRNSStereax® manufacturing plans update
26th Aug 20207:00 amRNSAnnual Report & Notice of AGM
14th Aug 20203:56 pmRNSHolding(s) in Company
14th Aug 20202:06 pmRNSSecond Price Monitoring Extn
14th Aug 20202:01 pmRNSPrice Monitoring Extension
24th Jul 20202:06 pmRNSSecond Price Monitoring Extn
24th Jul 20202:01 pmRNSPrice Monitoring Extension
17th Jul 20202:06 pmRNSSecond Price Monitoring Extn
17th Jul 20202:00 pmRNSPrice Monitoring Extension
17th Jul 202011:06 amRNSSecond Price Monitoring Extn
17th Jul 202011:02 amRNSPrice Monitoring Extension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:37 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSFinal Results
16th Jun 20207:00 amRNSCOVID-19 Update, Facility Re-opening
10th Jun 20204:14 pmRNSHolding(s) in Company
10th Jun 202011:05 amRNSSecond Price Monitoring Extn
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSTrading Update & Notice of Results
8th Jun 20204:42 pmRNSSecond Price Monitoring Extn
8th Jun 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSAppointment of Non-Executive Director
20th Apr 20207:00 amRNSCEO appointed as NED of Bacanora Lithium plc
6th Apr 20207:00 amRNSInvestor presentation
30th Mar 20204:25 pmRNSHolding(s) in Company
30th Mar 20202:40 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 202010:58 amRNSHolding(s) in Company
27th Mar 20209:00 amRNSAward of Share Options, Exercise of Options & TVR
25th Mar 20201:45 pmRNSResults of General Meeting and Open Offer & TVR
25th Mar 202011:06 amRNSSecond Price Monitoring Extn
25th Mar 202011:01 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSCOVID-19 Update
19th Mar 20204:15 pmRNSGeneral Meeting: Change of Venue
18th Mar 202011:07 amRNSSecond Price Monitoring Extn
18th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20205:20 pmRNSResult of Placing
6th Mar 20201:20 pmRNSProposed Placing & Open Offer
7th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
4th Feb 20207:00 amRNSSuccessful Stereax Field Trial
23rd Jan 20207:00 amRNSHalf-year Report
15th Jan 202011:06 amRNSSecond Price Monitoring Extn
15th Jan 202011:01 amRNSPrice Monitoring Extension
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
13th Jan 202011:08 amRNSSecond Price Monitoring Extn
13th Jan 202011:05 amRNSPrice Monitoring Extension
10th Jan 20202:07 pmRNSSecond Price Monitoring Extn
10th Jan 20202:01 pmRNSPrice Monitoring Extension
2nd Jan 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.